Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 187.12B | 195.61B | 218.94B | 263.31B | 184.63B | 119.70B |
Gross Profit | 52.59B | 55.53B | 62.37B | 81.21B | 52.01B | 19.61B |
EBITDA | 38.90B | 42.28B | 50.78B | 59.04B | 42.07B | 17.88B |
Net Income | 12.79B | 15.76B | 21.38B | 20.53B | 16.03B | -7.24B |
Balance Sheet | ||||||
Total Assets | 292.82B | 285.49B | 283.65B | 303.86B | 293.46B | 266.13B |
Cash, Cash Equivalents and Short-Term Investments | 25.61B | 30.55B | 33.43B | 41.77B | 33.66B | 35.90B |
Total Debt | 62.22B | 51.24B | 47.87B | 61.25B | 64.55B | 77.30B |
Total Liabilities | 173.81B | 165.23B | 164.20B | 189.29B | 178.46B | 160.05B |
Stockholders Equity | 116.64B | 117.86B | 116.75B | 111.72B | 111.74B | 103.70B |
Cash Flow | ||||||
Free Cash Flow | 11.42B | 15.95B | 22.96B | 31.68B | 18.07B | 4.04B |
Operating Cash Flow | 28.20B | 30.85B | 40.68B | 47.37B | 30.41B | 14.80B |
Investing Cash Flow | -20.80B | -17.33B | -16.45B | -15.12B | -13.66B | -13.08B |
Financing Cash Flow | -10.64B | -14.43B | -29.73B | -19.27B | -25.50B | 1.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | €6.14B | 17.26 | 77.67% | 4.68% | 35.00% | 24.05% | |
77 Outperform | €948.50M | 4.42 | 21.70% | 6.84% | -14.28% | -9.30% | |
73 Outperform | €787.50M | 14.15 | 4.13% | 49.86% | -8.54% | 47.48% | |
73 Outperform | €6.51B | 16.45 | ― | 2.25% | 17.19% | 11.76% | |
67 Neutral | €107.86B | 9.53 | 11.32% | 6.56% | -11.41% | -36.91% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
60 Neutral | €1.19B | 12.29 | -5.01% | 3.24% | -21.92% | -117.88% |